 | Up a level |
Journal Article
Brunner, Hermine I., Nanda, Kabita, Toth, Mary, Foeldvari, Ivan, Bohnsack, John, Milojevic, Diana, Rabinovich, C. Egla, Kingsbury, Daniel J., Marzan, Katherine, Chalom, Elizabeth, Horneff, Gerd, Kuester, Rolf-Michael, Dare, Jason A., Trachana, Maria, Jung, Lawrence K., Olson, Judyann, Minden, Kirsten, Quartier, Pierre, Bereswill, Mareike, Kalabic, Jasmina, Kupper, Hartmut, Lovell, Daniel J., Martini, Alberto and Ruperto, Nicolino 
ORCID: 0000-0001-8407-7782
(2020).
Safety and Effectiveness of Adalimumab in Patients With Polyarticular Course of Juvenile Idiopathic Arthritis: STRIVE Registry Seven-Year Interim Results.
Arthritis Care Res., 72 (10).
S. 1420 - 1431.
HOBOKEN:
WILEY.
ISSN 2151-4658
Brunner, Hermine I., Ruperto, Nicola, Lovell, Daniel J., Horneff, Gerd, Gamir-Gamir, Maria Luz, Hufnagel, Markus, Hsu, Joy, Bao, Min, Douglass, Wendy, Mallalieu, Navita L., Wells, Chris, Mala, Christopher M. and De Benedetti, Fabrizio (2018). Identification of Optimal Subcutaneous Doses of Tocilizumab in Children with Systemic Juvenile Idiopathic Arthritis. Arthritis Rheumatol., 70. HOBOKEN: WILEY. ISSN 2326-5205
Brunner, Hermine I., Ruperto, Nicola, Martini, Alberto, Ramanan, Athimalaipet V., Cuttica, Ruben J., Weiss, Jennifer E., Henrickson, Michael, Schmeling, Heinrike, Anton, Jordi, Minden, Kirsten, Horneff, Gerd, Luz Gamir-Gamir, Maria, Hufnagel, Markus, Douglass, Wendy, Wells, Chris, Wimalasundera, Sunethra, Mallalieu, Navita L., Lovell, Daniel J. and De Benedetti, Fabrizio (2018). Long-Term Safety of Subcutaneous Tocilizumab Administration in Systemic and Polyarticular Juvenile Idiopathic Arthritis. Arthritis Rheumatol., 70. HOBOKEN: WILEY. ISSN 2326-5205
Giancane, Gabriella ORCID: 0000-0003-2558-3559, Swart, Joost F., Castagnola, Elio, Groll, Andreas H., Horneff, Gerd, Huppertz, Hans-Iko, Lovell, Daniel J., Wolfs, Tom, Herlin, Troels, Dolezalova, Pavla, Sanner, Helga, Susic, Gordana, Sztajnbok, Flavio, Maritsi, Despoina, Constantin, Tamas, Vargova, Veronika, Sawhney, Sujata, Rygg, Marite, Oliveira, Sheila K., Cattalini, Marco, Bovis, Francesca, Bagnasco, Francesca ORCID: 0000-0003-1601-9518, Pistorio, Angela, Martini, Alberto, Wulffraat, Nico and Ruperto, Nicolino ORCID: 0000-0001-8407-7782
(2020).
Opportunistic infections in immunosuppressed patients with juvenile idiopathic arthritis: analysis by the Pharmachild Safety Adjudication Committee.
Arthritis Res. Ther., 22 (1).
LONDON:
BMC.
ISSN 1478-6362
Ravelli, Angelo, Consolaro, Alessandro ORCID: 0000-0002-0065-7614, Horneff, Gerd, Laxer, Ronald M., Lovell, Daniel J., Wulffraat, Nico M., Akikusa, Jonathan D., Al-Mayouf, Sulaiman M., Anton, Jordi ORCID: 0000-0002-8792-4219, Avcin, Tadej, Berard, Roberta A., Beresford, Michael W., Burgos-Vargas, Ruben ORCID: 0000-0003-1058-8955, Cimaz, Rolando, De Benedetti, Fabrizio, Demirkaya, Erkan, Foell, Dirk, Itoh, Yasuhiko ORCID: 0000-0002-4999-6473, Lahdenne, Pekka, Morgan, Esi M., Quartier, Pierre, Ruperto, Nicolino ORCID: 0000-0001-8407-7782, Russo, Ricardo ORCID: 0000-0002-1256-8483, Saad-Magalhaes, Claudia, Sawhney, Sujata, Scott, Christiaan, Shenoi, Susan, Swart, Joost F., Uziel, Yosef, Vastert, Sebastiaan J. and Smolen, Josef S.
(2018).
Treating juvenile idiopathic arthritis to target: recommendations of an international task force.
Ann. Rheum. Dis., 77 (6).
S. 819 - 829.
LONDON:
BMJ PUBLISHING GROUP.
ISSN 1468-2060
Ruperto, Nicolino ORCID: 0000-0001-8407-7782, Brunner, Hermine I., Quartier, Pierre, Constantin, Tamas, Wulffraat, Nico M., Horneff, Gerd, Kasapcopur, Ozgur ORCID: 0000-0002-1125-7720, Schneider, Rayfel, Anton, Jordi ORCID: 0000-0002-8792-4219, Barash, Judith, Berner, Reinhard ORCID: 0000-0002-6216-9173, Corona, Fabrizia, Cuttica, Ruben, Fouillet-desjonqueres, Marine, Fischbach, Michel, Foster, Helen E., Foell, Dirk, Radominski, Sebastiao C., Ramanan, Athimalaipet V., Trauzeddel, Ralf, Unsal, Erbil, Levy, Jeremy, Vritzali, Eleni, Martini, Alberto and Lovell, Daniel J.
(2018).
Canakinumab in patients with systemic juvenile idiopathic arthritis and active systemic features: results from the 5-year long-term extension of the phase III pivotal trials.
Ann. Rheum. Dis., 77 (12).
S. 1710 - 1720.
LONDON:
BMJ PUBLISHING GROUP.
ISSN 1468-2060